Efficacy and prognosis of neoadjuvant chemotherapy is correlated with breast cancer molecular classification. [electronic resource]
Producer: 20151001Description: 517-22 p. digitalISSN:- 0946-1965
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- Chemotherapy, Adjuvant
- Chi-Square Distribution
- Disease Progression
- Disease-Free Survival
- Docetaxel
- Epirubicin -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Neoadjuvant Therapy
- Neoplasm Grading
- Precision Medicine
- Predictive Value of Tests
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Remission Induction
- Risk Factors
- Taxoids -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.